BamSEC and AlphaSense Join Forces
Learn More

Iovance Biotherapeutics Inc.

NASDAQ: IOVA    
Share price (12/20/24): $7.38    
Market cap (12/20/24): $2.249 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 44 pages Fourth Amended and Restated Bylaws of Iovance Biotherapeutics, Inc. (A Delaware Corporation) as Adopted by the Board of Directors on March 28, 2024
12/34/56
EX-3.1
from 8-K 37 pages State of Delaware Certificate of Conversion From a Non-Delaware Corporation to a Delaware Corporation Pursuant to Section 265 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 44 pages Third Amended and Restated Bylaws of Iovance Biotherapeutics, Inc. (A Delaware Corporation) as Adopted by the Board of Directors on April 25, 2022 and to Be Effective on the First Calendar Day Following the 2022 Annual Meeting of Stockholders to Be Held on or About June 10, 2022
12/34/56
EX-3.1
from 8-K 36 pages Second Amended and Restated Bylaws of Iovance Biotherapeutics, Inc. (A Delaware Corporation) as Adopted by the Board of Directors on April 20, 2021 and to Be Effective on the First Calendar Day Following the 2021 Annual Meeting of Stockholders to Be Held on or About June 11, 2021
12/34/56
EX-3.1
from 8-K 35 pages Amended and Restated Bylaws of Iovance Biotherapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Incorporation, as Amended, of Iovance Biotherapeutics, Inc
12/34/56
EX-3.5
from POS AM 18 pages Certificate of Designation of Rights, Preferences and Privileges of Series B Preferred Stock of Lion Biotechnologies, Inc. Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.4
from POS AM 21 pages Certificate of Designation of Rights, Preferences and Privileges of Series a Convertible Preferred Stock of Lion Biotechnologies, Inc. Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.2
from 8-K 1 page Amendment to the Bylaws of Lion Biotechnologies, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Certificate of Incorporation of Lion Biotechnologies, Inc
12/34/56
EX-3.4
from 8-K 34 pages Bylaws of Lion Biotechnologies, Inc
12/34/56
EX-3.3
from 8-K 7 pages Certificate of Incorporation of Lion Biotechnologies, Inc
12/34/56
EX-3.2
from 8-K 1 page State of Delaware Certificate of Conversion From a Non-Delaware Corporation to a Delaware Corporation Pursuant to Section 265 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K 20 pages Amended and Restated Bylaws of Lion Biotechnologies, Inc. a Nevada Corporation
12/34/56
EX-3.1
from 8-K 17 pages Certificate of Designation of Rights, Preferences and Privileges of Series B Preferred Stock of Lion Biotechnologies, Inc. a Nevada Corporation
12/34/56
EX-3.1
from 8-K 21 pages Certificate of Designation of Rights, Preferences and Privileges of Series a Convertible Preferred Stock of Lion Biotechnologies, Inc. a Nevada Corporation
12/34/56
EX-3.1
from 8-K 1 page Genesis Biopharma, Inc. Certificate of Amendment of Bylaws
12/34/56
EX-3.1
from 10-Q 13 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1.3
from 8-K ~5 pages Articles of Merger
12/34/56